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Sequence variant at 8q24.21 associates with
sciatica caused by lumbar disc herniation
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Lumbar disc herniation (LDH) is common and often debilitating. Microdiscectomy of her-
niated lumbar discs (LDHsurg) is performed on the most severe cases to resolve the resulting
sciatica. Here we perform a genome-wide association study on 4,748 LDHsurg cases and
282,590 population controls and discover 37 highly correlated markers associating with
LDHsurg at 8q24.21 (between CCDC26 and GSDMC), represented by rs6651255[C]
(OR¼0.81; P¼ 5.6 10 12) with a stronger effect among younger patients than older. As
rs6651255[C] also associates with height, we performed a Mendelian randomization analysis
using height polygenic risk scores as instruments to estimate the effect of height on LDHsurg
risk, and found that the marker’s association with LDHsurg is much greater than predicted by
its effect on height. In light of presented ﬁndings, we speculate that the effect of rs6651255
on LDHsurg is driven by susceptibility to developing severe and persistent sciatica upon LDH.
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S
ciatica describes the often debilitating form of neuropathic
pain that radiates along the sciatic nerve (radiculopathy)1.
While sciatica can be of various etiologies, the majority of
cases (85–90%) are caused by lumbar disc degeneration (LDD)
resulting in herniation of disc material from the nucleus pulposus
into the epidural space, leading to mechanical and/or chemical
insult to affected nerve roots1–3.
The pathophysiology of lumbar disc herniation (LDH) is
not completely understood4. Imaging studies of different
populations have shown that LDD starts in early adolescence
and affects the majority of people over the course of their life5–7.
Therefore, drawing a diagnostic line between normal
consequences of aging and pathological disc changes remains
challenging5. Twin studies suggest that genetics strongly inﬂuence
various radiological signs of LDD with heritability estimated up
to 74% (95% conﬁdence interval (CI) 64–81%)8,9. However, the
search for genetic risk factors has not yielded conclusive
results10,11. A recent genome-wide association study (GWAS),
utilizing a quantitative measure created from radiological signs of
LDD (lumbar disc space narrowing and presence of osteophytes)
in 4,600 individuals of European descent, uncharacterized for
LDD symptoms, identiﬁed four single-nucleotide polymorphisms
(SNPs) with P between 1.8 10 9 and 3.3 10 8 (effect (b)
between  0.13 and 0.23)12.
Although herniated lumbar discs are the most common cause
of sciatica, they are also observed in up to 50% of asymptomatic
adults by magnetic resonance imaging13–15. Furthermore, about a
third of symptomatic LDH resolve within weeks or months
regardless of intervention13,16,17 with only a fraction (5–10%)
leading to persistent sciatica or radiculopathy requiring
surgery18,19. Microdiscectomy, a minimally invasive spinal
surgery for removal of herniated lumbar disc tissue, is indicated
only for individuals with severe, progressive and persistent
sciatica symptoms that are consistent with location of the
radiologically conﬁrmed herniated disc13,20. These surgical
criteria, therefore, deﬁne a clear and speciﬁc phenotype of
sciatica secondary to LDH pathology that we here show associates
strongly with a sequence variant at 8q24.21 between GSDMC and
CCDC26. Our results provide novel insights into the biological
underpinnings of this painful condition.
Results
A sequence variant at 8q24.21 associates with LDHsurg.
We performed a GWAS of 4,748 Icelanders who underwent
microdiscectomy of a herniated lumbar disc (LDHsurg) and
282,590 population controls. The sample represents 90% of those
undergoing this surgical procedure in Iceland over an 18 year
period or from 1997–2015 (Table 1).
We applied genome-wide signiﬁcance thresholds weighted for
variant classes, using the threshold of Po1.1 10 9 assigned to
variants in the lowest impact functional class21 (Methods).
Altogether, 37 highly correlated sequence variants (r2 with top
marker40.78) associating with LDHsurg were identiﬁed, located
at 8q24.21 between GSDMC and CCDC26 and spanning B20 kb
(chr8:129,705,470–129,726,726, hg38) (Fig. 1, Supplementary
Fig. 1 and Supplementary Table 1). The most signiﬁcant
association was with rs6651255[C] (AF¼ 23%; odds ratio
(OR)¼ 0.81; 95% CI¼ 0.77, 0.86; P¼ 5.6 10 12, a w2-test was
used to calculate P values for all GWAS associations) (Methods).
Conditional analysis showed that the signal of 37 variants is fully
accounted for by rs6651255[C] (all adjusted PZ0.15) and no
other markers within±2Mb reached signiﬁcance. The effect of
rs6651255 on LDHsurg did not differ by gender (male vs female
P¼ 0.85). A signiﬁcant difference in effects was, however,
observed when comparing those who underwent LDHsurg at
an earlier age (r40 years) to those aged 41 years and older at ﬁrst
LDHsurg (P¼ 1.8 10 3) (Table 2).
The LDHsurg signal at 8q24.21 does not associate with cancer.
The 8q24.21 region, containing MYC and PVT1, is known to host
a number of variants associating with risk of several cancer
types22–25. However, that region is about 2Mb upstream of
rs6651255. None of the reported markers for cancer in the
8q24.21 region correlate with the LDHsurg signal. Searching for
associations of rs6651255[C] with several common cancers26
revealed no signiﬁcant association once the number of tests had
been taken into account. The closest protein coding gene
(B370 kb downstream) is GSDMC, a gene initially found by
researchers seeking genes upregulated in metastatic mouse
melanoma cells (hence also termed MLZE)27. Besides
expression in skin epithelium, GSDMC is primarily expressed in
trachea and spleen and although its function is largely unknown,
as a member of the Gasdermin superfamily, it is thought to be
involved in regulation of epithelial cell development, apoptosis,
carcinogenesis and immune-related functions28–31.
Approximately 30 kb upstream of rs6651255 is the full-length
mRNA encoding CCDC26. Also known as RAM, CCDC26
encodes a retinoic acid-dependent modulator of myeloid
differentiation32,33. Retinoic acid is involved in regulation
of skeletal growth, chondrocyte proliferation and aggrecan
(the major proteoglycan component of the intervertebral disc)
expression and content34. Indeed, CCDC26 was considered
a candidate gene in a GWAS of cleft lip showing a strong
association with a variant (rs987525) located B400 kb upstream
of CCDC26 (ref. 35). This cleft lip variant is 800 kb upstream of
rs6651255 (r2¼ 0.00056, D0 ¼ 0.084) and in the present study
showed no association with LDHsurg in the Icelandic sample
(OR¼ 0.98, P¼ 0.40). Including rs987525, there are further four
SNPs listed in the GWAS catalogue (URLs) located in or near
GSDMC or CCDC26. They are rs4295627 associating with glioma,
rs10098310 with monocyte count and rs4733724 and rs6470764
with height. Testing these variants in corresponding Icelandic
phenotypes shows that SNPs in this region behave comparably in
Icelandic data as in other populations (Supplementary Table 2).
The effects of rs6651255 on LDHsurg and height. Three out of
the 37 correlated SNPs representing the LDHsurg signal have
Table 1 | Demographics of cases.
Phenotype N Age M (s.d.) n with genotypes % with genotypes
LDHsurg 5,288 44.9 (13.7) 4,748 89.8
Males 3,061 44.3 (13.7) 2,762 90.2
Females 2,227 45.7 (13.7) 1,986 89.2
LDHsurgp40 years 2,771 33.1 (6.1) 1,897 68.5
GWAS, genome-wide association studies; LDHsurg, herniated lumbar discs.
Total number of cases undergoing microdiscectomy of an LDHsurg in Iceland 1997–2015 (N) and proportion of cases with genotypes included in the GWAS study (n).
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previously been reported to associate with adult human height in
large meta-analyses36–38 (Supplementary Tables 2 and 3). All are
highly correlated with rs6651255 (r240.9 in Iceland).
Consistently, rs6651255[C] associating with lower risk of
LDHsurg, also associates with less height in the Icelandic data
(b¼  0.03 s.d. (corresponding to  0.2 cm), P¼ 2.2 10 5;
N¼ 88,835, w2 test). However, neither rs6470764[T] representing
rs6651255, nor any of the 16, out of the 37 correlated SNPs of the
signal that were tested in the GIANT BMI meta-analysis39,
associate with BMI (lowest P value of 0.10 (b¼ 0.007; s.e.¼ 0.004;
N¼ 321,563)).
Consistent with previous epidemiological results40, we
observed a positive association between adult height and risk of
LDHsurg in Icelandic patients (OR¼ 1.25 for 10 cm increase in
height; P¼ 4.6 10 10; Ncase¼ 1,929; Ncontrol¼ 79,883, t-test)
(Methods). To examine to what degree known adult height
variants collectively explain the association with LDHsurg, we
computed adult height polygenic scores, based on adjusted
GWAS scores for 1.7 million markers tested in the GIANT
study37 (excluding Icelandic data), for Icelanders who had been
genotyped with various Illumina SNP chips (Methods). In our
data the adult height polygenic scores signiﬁcantly associate with
LDHsurg case–control status (OR¼ 1.36 for 10 cm increase in
height; P¼ 8.4 10 6; Ncase¼ 3,085; Ncontrol¼ 132,822, t-test).
Given that adult height variants associate collectively with
LDHsurg and a SNP corresponding to the LDHsurg signal
(rs4733724, Supplementary Table 3) was among the 697 adult
height variants reported by the GIANT meta-analysis37, we tested
whether the other 696 GIANT variants associate independently
with LDHsurg (Fig. 2, Methods). While Fig. 2 demonstrates a
small positive correlation (R2¼ 0.0072, P¼ 0.026, t-test) between
effects of these GIANT variants on height and logarithm of their
LDHsurg risk (logOR), none of the other GIANT variants
signiﬁcantly associate with LDHsurg at a threshold of 7.2 10 5
(Po0.05/697). The SNP representing our top marker is a clear
outlier (Fig. 2). Using the slope from the correlation plot in Fig. 2,
the predicted effect of rs6651255[C] on LDHsurg, through its
effect on height, would result in an odds ratio of 0.99, showing
that the LDHsurg effect is not proportional to the height effect.
These analyses clearly show that the effect of rs6651255 on
LDHsurg greatly surpasses that expected due to its effect on
height (Fig. 2).
Characterizing rs6651255 effects on related phenotypes. In
light of potential structural effects of rs6651255[C] implied by its
height association, we also investigated the variant’s effect on
available phenotypes relating to vertebral bone structure in
Icelandic data41. The variant did not associate with osteoarthritis
of the spine (OR¼ 0.96; P¼ 0.35), bone mineral density of the
spine (b¼  0.01; P¼ 0.31), or osteoporotic vertebral fractures
(OR¼ 1.02; P¼ 0.64) (Supplementary Table 4).
As coded radiological reports for this large sample of LDHsurg
cases were unavailable for the study, we tested all published
markers (Po10 5) from the previously mentioned GWAS
of radiologically deﬁned LDD (a quantitative trait phenotype
based on lumbar disc space narrowing and osteophytes growth)12
for association with our LDHsurg phenotype. None of the
44 markers associates with risk of undergoing LDHsurg
(Po0.05/44¼ 1.1 10 3, Supplementary Table 5).
To further characterize the effects of rs6651255, we
identiﬁed an independent sample of Icelandic cases from hospital
records (Ncase¼ 930) diagnosed as the LDHsurg cases,
(with intervertebral disc disorder with radiculopathy represented
by ICD-10 code M51.1) who, however, had no history of
LDHsurg. This indicating that their associated sciatica symptoms
resolved over time and did not become severe enough to warrant
surgery. There was no association observed with rs6651255 in this
sample (OR¼ 0.95; P¼ 0.50).
Taken together, these ﬁndings suggest that the effect of
rs6651255 on risk of undergoing LDHsurg is driven, not
primarily by the morphology associated with herniated lumbar
discs, but rather by the severity and persistence of associated
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Figure 1 | Regional association plot for the 8q24.21 intergenic
locus that associates with undergoing LDHsurg (N¼4,748). P values
( log10) of SNP association with LDHsurg in Iceland is plotted against
their positions at the 8q24.21 locus. SNPs are coloured to reﬂect their LD
with rs6651255 (chr8:129711546) (purple diamond) in the data set. The
right y axis shows calculated recombination rates at the chromosomal
location, plotted as solid grey lines. Known genes in the region are shown
underneath the plot, taken from the UCSC genes track in the UCSC
Genome Browser. All positions are in in NCBI Build 38 coordinates.
A w2-test was used to calculate P values.
Table 2 | GWAS results for variant rs6651255[C] in LDHsurg in Iceland.
Phenotype N OR 95% CI P
LDHsurg 4,748 0.81 (0.77, 0.86) 5.61 10 12
LDHsurgp40yrs* 1,898 0.72 (0.65, 0.79) 3.20 10 11
LDHsurg440yrs* 2,850 0.87 (0.81, 0.93) 9.63 10 5
CI, conﬁdence interval; GWAS, genome-wide association studies; LDHsurg, herniated lumbar discs; OR, odds ratio.
A w2-test was used to compute P values.
*Younger vs older P¼ 1.8 10 3.
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sciatica. We therefore tested whether rs6651255[C] associated
with chronic or neuropathic pain in independent Icelandic
samples with ﬁbromyalgia (Ncase¼ 2,142), temporomandibular
joint disorder (TMD, Ncase¼ 1,455) and migraine (Ncase¼ 3,816),
in addition to a small sample with neuropathic pain as
determined by the DN4 screening questionnaire (Ncase¼ 394)
(Methods). No signiﬁcant associations with rs6651255 were
detected. As larger sample sizes are needed to reach deﬁnite
conclusions we provide the association results (Supplementary
Table 6) to facilitate future meta-analysis efforts.
Effect of rs6651255 on expression of nearby genes. Finally, to
assess the potential effect of rs6651255 on gene expression
(eQTL) we examined data from the Genotype-Tissue Expression
(GTEx) project (URLs) available from multiple tissues, however,
not including tissue from the intervertebral disc. In GTEx data,
rs6651255 has a signiﬁcant eQTL (cis window deﬁned as ±1Mb
around gene transcript start site, false discovery rateo0.05) with
GSDMC in two tissues; esophagus-mucosa (P¼ 9.2 10 14) and
Sun-exposed skin of lower leg (P¼ 4.5 10 10), while associa-
tion with CCDC26 (RP11-274M4.1) was only present in esopha-
gus-mucosa (P¼ 3.7 10 6) (Supplementary Table 7). However,
the best LDHsurg association signal (represented by rs6651255)
and the best eQTL in the same tissues do not coincide. The
variant rs4345520 has the most signiﬁcant eQTL with GSDMC
(esophagus-mucosa, P¼ 3.0 10 42; Skin—Sun-exposed (lower
leg), P¼ 3.3 10 28) and rs10092783 the most signiﬁcant
eQTL with CCDC26 (RP11-274M4.1) (esophagus-mucosa,
P¼ 6.7 10 16). These two variants are highly correlated
(r2¼ 0.82), while they are moderately correlated with rs6651255
(all r2o0.29). (Supplementary Table 7). In addition, a cis-eQTL
analysis was performed in the Icelandic data based on
RNA sequencing of white blood cells (N¼ 1,002) and adipose
tissue (N¼ 673) samples. We assessed associations with probes
from the ﬁve genes within ±500Kb of rs6651255 (Fig. 1). At
a signiﬁcance threshold of 1.0 10 2 (Po0.05/5) we did not
observe associations of rs6651255 with gene expression in white
blood cells or adipose tissue.
Discussion
We have discovered an association between common, correlated,
intergenic sequence variants and risk of undergoing micro-
discectomy of a herniated lumbar disc (LDHsurg); a spinal
surgery performed to alleviate persistent and painful sciatica
symptoms. The signal is represented by rs6651255[C] that also
associates with less height, potentially reﬂecting structural effects
involved in the pathogenesis of LDH. However, our results show
that this variant does not affect risk of LDHsurg through height
(Fig. 2). In addition, rs6651255 does not affect the skeletal
phenotypes that we tested; osteoarthritis of the spine, bone
mineral density of the spine or vertebral osteoporosis, nor did we
ﬁnd associations between markers from the only identiﬁed
GWAS of morphological changes associated with LDD (albeit
only radiologically deﬁned without symptom characterization)12.
Indeed, clinical studies have established that there is an unclear
relationship between radiological signs of LDH and degree of
sciatica or other clinical symptoms15. In keeping with the main
indication for LDHsurg13,20; the neuropathic and painful
symptoms of sciatica, we ﬁnd of interest that height is inversely
correlated with peripheral nerve conduction velocity42 and has
been shown to increase risk of peripheral sensory neuropathy in
diabetes43, peripheral insensate neuropathy44, HIV neuropathy45
and post-mastectomy neuropathic pain syndrome46. While the
pathogenesis behind the relationship between height and
neuropathic pain is unclear, increased height in humans is
known to associate with increased axonal length and greater axon
surface area47. The weak, but directionally consistent association
(OR¼ 0.83, P¼ 0.04) of rs6651255[C] with neuropathic pain as
measured by the DN4 is of interest in this context, but requires
further study in larger samples.
When selecting cases for microdiscectomy, neurosurgeons have
established that the herniated disc material is likely to cause the
associated sciatica symptoms13,20. Indeed in most cases, rapid
symptom relief follows microdiscectomy, but in up to 20% of
cases symptoms persist after surgery13,18,48,49. Besides the
symptoms caused by mechanical compression on nerve roots
by the herniated lumbar disc, inﬂammatory and immunological
consequences are also considered a factor in sciatica symptom
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Figure 2 | Correlation of GIANT variants’ effect on height and risk of LDHsurg. Scatter plot showing how the 689 out of 697 adult height variants
reported by GIANT37 that we have LDHsurg association results for, affect adult height (x axis) and LDHsurg (y axis) in our data. The effect allele
(minor or major) of each variant was concluded to be the one that has a positive effect on adult height in our data. The black solid line,
y¼0.0010þ0.22xþ e, represents weighted linear regression, excluding rs4733724, with R2¼0.0072 and P¼0.026, using MAF(1-MAF) as weights.
A t-test was used to calculate P value.
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severity and duration50,51. Of interest in this context is
that GSDMC, downstream of rs6651255, is highly expressed
in the spleen27 which plays a signiﬁcant role in adaptive immune
responses52. While the role of the immune system in regression
of herniated discs and/or development of sciatica is not clear,
the immune system is known to become activated by
the otherwise immune-privileged nucleus pulposus as it
herniates from its protected environment into the immune-
regulated epidural space53. The subsequent migration of immune
cells into the herniated disc tissues and increased expression
of inﬂammatory cytokines is accompanied by the ingrowth of
nociceptive nerve ﬁbres into the disc, a process thought
to contribute to the pathogenic development of the associated
painful symptoms53.
The surgically deﬁned phenotype used in this study
was selected to represent a severe, symptomatic form of LDD,
that is, herniated lumbar disc with sciatica indicating LDHsurg.
In light of the clear clinical criteria associated with this type
of surgery and the ﬁndings presented here, we speculate that the
observed effect of rs6651255 on risk of undergoing LDHsurg is
mainly driven by the severity of symptoms, that is, susceptibility
to developing persistent and painful sciatica in the presence of
the mechanical and biochemical nerve root insult created by
a herniated lumbar disc. While our ﬁndings await replication
in a comparable sample, we have provided compelling evidence
for this variant having a signiﬁcant role in the development of
sciatica resulting from a herniated lumbar disc. The observed
association in the Icelandic population is highly signiﬁcant
and we were able to exclude that the effect on sciatica is solely
through the variant’s effect on height. However, it is clear that
further studies are required to complete this complicated but
intriguing picture.
Methods
Study populations and phenotypes. Data on microsurgical excision of herniated
lumbar intervertebral discs (LDHsurg) were obtained from the Landspitali
National University Hospital (Landspitali) databases of surgical procedures
(that is, lumbar microdiscectomy with surgical code ABC16 according to the
NOMESCO (Nordic Medico-Statistical Committee) system)54. The so-deﬁned
phenotype is represented in the current paper by ‘LDHsurg’. Demographics of the
deﬁned sample are presented in Table 1. Landspitali is a tertiary reference centre
hospital and the only hospital in Iceland offering neurosurgery. Microdiscectomy
consists of removing a portion of the intervertebral disc, the herniated or
protruding portion that is compressing the traversing spinal nerve root, by way
of a small incision and using a surgical microscope. This well-established technique
has become the most common surgery performed by neurosurgeons in Iceland and
elsewhere13,20. It was ﬁrst performed in Landspitali in 1981 and has since become
standard treatment for herniated lumbar discs with persistent, painful sciatica or
radiculopathy that does not respond to conservative treatment20. The data used in
the present study cover microdiscectomy surgeries performed in the hospital’s
Department of Neurosurgery over a period of 18 years (1997–2015). As shown in
Table 1, the proportions of genotyped cases out of the total cases undergoing
microdiscectomy surgery during this period support non-bias in the discovery
phenotype. Data on individuals diagnosed with herniated intervertebral discs with
radiculopathy (ICD-10 code M51.1) who did not undergo microdiscectomy
(LDHsurg), were obtained from the Landspitali database of discharge diagnoses
(for the same time period as LDHsurg, or 1997–2015). During this period, M51.1
was the most prevalent hospital diagnosis preceding LDHsurg, with a total of 6,280
individuals with this diagnosis. The 5,288 individuals who underwent LDHsurg
(Table 1) were excluded as were those diagnosed with M51.1 within 6 months of
the end of the study period in 2015, to ascertain that we did not include newly
diagnosed cases that would within 6 months become candidates for LDHsurg
(according to clinical guidelines in Iceland, LDHsurg is performed if symptoms
progress and/or severity persists for 2–3 months). Age and gender distribution of
this sample of conﬁrmed LDH without LDHsurg was comparable to the larger
LDHsurg sample (Supplementary Table 8).
Height measurements from 88,835 Icelanders were collected in deCODE‘s
resident assessment instrument studies. Height (cm) was either measured
using a stadiometer with the subjects wearing no shoes or self-reported on
questionnaires by individuals. Adult height measurements were corrected for year
of birth and standardized separately for each of the sexes to have a standard normal
distribution. Measured and self-reported heights were corrected separately. Height
measurements were available for 1929 LDHsurg cases and 79,886 controls.
Information on vertebral osteoarthritis and bone mineral density was obtained
from the Landspitali electronic health records. Secondary osteoarthritis and
post-trauma osteoarthritis were excluded from the list. Bone densitometry
(DEXA, Hologic QDR4500A) was also obtained from Landspitali41. Bone mineral
density of the spine (L2-L4) was age and weight corrected and standardized in
each gender separately. Vertebral fractures were self-reported in a detailed
questionnaire of osteoporosis related information, using additional hospital data
to increase classiﬁcation accuracy, for example, by excluding high-trauma
fractures, corticosteroid users, and women with early menopause from the fracture
list41.
The Icelandic migraine sample was recruited from various sources including
diagnoses from neurologists and self-reported migraine according to a validated
questionnaire as has been described in detail elsewhere55. Fibromyalgia cases were
characterized by a rheumatologist heading the only clinic in Iceland specializing in
diagnosis and treatment of ﬁbromyalgia. All patients were diagnosed according to
the 2010 American College of Rheumatology (ACR) criteria56. Data on TMD were
obtained via the dental department at the University of Iceland. All patients
were diagnosed by dentists specializing in TMD following the diagnostic criteria
for temporomandibular disorders (DC/TMD)57. Patients with a history of
TMD secondary to trauma were excluded. Participants in the deCODE pain
projects who answered the DN4 screening questionnaire for neuropathic pain58
were recruited on the basis of having various chronic pain conditions (chronic pain
deﬁned as lasting 3 months or longer) in addition to post-surgical patients who by
the nature of their surgery had sustained neural lesions. On the basis of studies
evaluating sensitivity and speciﬁcity of DN4 scores compared with clinical
diagnoses of neuropathic pain, those who scored 4 and above on the DN4 scale of
0–7 were classiﬁed as having neuropathic pain58.
All samples and questionnaire data were collected through studies approved by
the National Bioethics Committee and the Data Protection Authority in Iceland.
Data were analysed within the context of a study on the genetics of chronic and
neuropathic pain with permission from the National Bioethics Committee
(VSNb2012090009/03.12) and overseen by the Data Protection Authority. All
participants signed informed consent before blood samples were drawn. All
personal identiﬁers were encrypted by a third-party system overseen by the
Icelandic Data Protection Authority59. The association studies were performed
using genotypes from these data in addition to whole-genome sequence data and
imputation approaches previously outlined60 and further described below.
Genotyping and imputation. Genotyping and imputation methods and the
association analysis method in the Icelandic samples are previously described60
with some modiﬁcations described here. The whole genomes of 8,453 Icelanders
were sequenced using Illumina technology to a mean depth of at least  10
(median  32). SNPs and indels were identiﬁed and genotypes called using joint
calling with the Genome Analysis Toolkit HaplotypeCaller (GATK version 3.3.0)
(ref. 61). The sequence variants identiﬁed in the 8,453 sequenced Icelanders were
then imputed into 150,656 Icelanders who had been genotyped with various
Illumina SNP arrays and their genotypes phased using long-range phasing60. Using
familial imputation60, the sequence variants were imputed into untyped relatives of
the array-typed to further increase the sample size for association analysis and
increased the power to detect associations. Individuals who had undergone
LDHsurg were either genotyped individuals (N¼ 3,097) or untyped ﬁrst and
second degree relatives of genotyped individuals (N¼ 1,651). The group of controls
consisted of array-typed individuals (N¼ 132,966) and untyped ﬁrst and second
degree relatives (N¼ 149,624); resulting in 282,590 population controls. A total of
21.6 million variants were used in the association analysis under an additive model.
All of the tested variants had imputation information over 0.85 and met quality
control standards60.
Sample preparation and DNA whole-genome sequencing methods. Our
dataset contains samples obtained using three different library preparation
methods from Illumina. In addition sequencing was performed using three
different types of Illumina sequencing instruments.
(a) Standard TruSeq DNA library preparation method. Illumina GAIIx and/or
HiSeq 2000 sequencers.
(b) TruSeq DNA PCR-free library preparation method. Illumina HiSeq
2500 sequencers.
(c) TruSeq Nano DNA library preparation method. Illumina HiSeq X sequencers.
The Standard TruSeq DNA library preparation method involves isolating
approximately 1 mg of genomic DNA from frozen blood samples and fragmenting
to a mean target size of B300–400 bp using a Covaris E210 instrument. The
resulting fragmented DNA was end repaired using T4 and Klenow polymerases
and T4 polynucleotide kinase with 10mM dNTP followed by addition of
an ’A’ base at the ends using Klenow exo fragment (30 to 50-exo minus) and dATP
(1mM). Sequencing adaptors containing ’T’ overhangs were ligated to the DNA
products followed by agarose (2%) gel electrophoresis. Fragments ofB450–500 bp
were isolated from the gels (QIAGEN Gel Extraction Kit), and the adaptor-
modiﬁed DNA fragments were PCR enriched for ten cycles using Phusion DNA
polymerase (Finnzymes Oy) and a PCR primer cocktail (Illumina) needed for
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paired-end sequencing. Enriched libraries were puriﬁed using AMPure XP beads.
The quality and concentration of the libraries were assessed with the Agilent
2100 Bioanalyzer using the DNA 1000 LabChip. Libraries were stored at
 20 C. Sequencing-by-synthesis (SBS) was performed on either Illumina
GAIIx or HiSeq 2000 instruments, respectively. Paired-end libraries were
sequenced using 2 76, 2 101 or 2 120 cycles of incorporation and imaging
with Illumina SBS kits, TruSeq v5 for the GAIIx. For the HiSeq 2000, 2 101 cycles
with SBS kits v2.5 or v3 were employed. Each library was initially run on a single
lane on a GAIIx for validation, assessing optimal cluster densities, insert size,
duplication rates and comparison with chip genotyping data. Following validation,
the desired sequencing depth ( 10 to  30) was then obtained using either
sequencing platform. Targeted raw cluster densities ranged from 500–800K 1
mm 2, depending on the version of both the sequencing chemistry and the data
imaging/analysis software packages (SCS.2.8/RTA1.8 or SCS2.9/RTA1.9 for the
GAIIx and HCS1.3.8. or HCS1.4.8 for HiSeq 2000). Real-time analysis involved
conversion of image data to base calling in real-time.
Using the TruSeq DNA PCR-free library preparation method, paired-end
libraries for sequencing were prepared according to the manufacturer’s instructions
(Illumina, TruSeq DNA PCR-free). In short, B1 mg of genomic DNA, isolated
from frozen blood samples, was fragmented to a mean target size of 350 bp
using a Covaris E210 ultrasonicator followed by clean-up using AmPure
XP puriﬁcation beads. Blunt-end DNA from the resulting fragments was generated
using a mix of 30450 exonuclease and 50430 polymerase activities, respectively,
followed by 50-phosphorylation using T4 polynucleotide kinase. Size-selection of
the blunt-end fragments was done using a two-step puriﬁcation strategy with
different ratios of the AmPure XP puriﬁcation beads ( 0.6 and  1). Finally,
30-adenylation and ligation of barcoded adapters was performed, followed by clean-
up with magnetic beads. The quality and concentration of the libraries were
assessed with the Agilent 2100 Bioanalyzer using the DNA 1000 LabChip (Agilent).
Barcoded libraries were stored at  20 C. All steps in the workﬂow were
monitored using an in-house laboratory information management system
with barcode tracking of all samples and reagents. All samples were ﬁrst pooled
(12–24 plex) and sequenced on Illumina’s MiSeq instruments (2 25 cycles) to
assess quality and effective concentration of sequencing libraries. Subsequent deep
sequencing was done on HiSeq 2500 instruments, were each sample was sequenced
on three lanes, generating 4100Gb of raw data and at least 30X coverage.
Sequencing was done using TruSeq v3 reagents, paired-end 2 100 cycles.
System operation and base calling in real-time was done using HCS 2.2.38 and
RTA 1.18.61.
Finally, the TruSeq Nano DNA library preparation method involves sample
preparation and sequencing using a method that is essentially the same as
described above for the TruSeq DNA PCR-free method, except the input amount
was 100 ng of genomic DNA (instead of 1 mg) and following clean-up of
adapter ligated DNA, the samples were enriched by eight-cycles of PCR using
a PCR primer cocktail, followed by Ampure XP bead clean-up. The quality and
concentration of the libraries were assessed with the Perkin Elmer LabChip
GX instrument using the HT DNA HiSens reagent kit. Sequencing was done using
the HiSeq X HD reagent kit. Each sample was loaded onto the HiSeq X instrument
at a concentration of 300 pM and sequenced to high depth (430 ). System
operation and base calling in real-time was done using HCSX 3.1.26 and
RTA2 2.3.9.
Association analysis. Association testing for case–control analysis was performed
using logistic regression, adjusting for gender, age and county. A generalized
form of linear regression was used to test for association of quantitative traits
with SNPs.
Our method of testing for association takes the closest relatedness into account
using a mixed effect model60. To further account for inﬂation in test statistics due
to relatedness and stratiﬁcation, we applied the method of linkage disequilibrium
(LD) score regression62. With a set of 1.1M variants we regressed the w2 statistics
from our GWAS scan against LD score and used the intercept as a correction
factor. The LD scores were downloaded from an LD score database (URL’s).
The estimated correction factor was 1.15 for LDHsurg, 1.05 for LDHsurg r40yrs,
1.08 for LDHsurg440yrs, 1.08 for LDHsurg males and 1.06 for LDHsurg females.
The correction factor was 1.48 for adult height, 1.07 for osteoporosis with vertebral
fractures, 1.44 for osteoarthritis of the spine, 1.14 for bone mineral density of spine,
1.01 for LDH (ICD-10 code M51.1) excluding LDHsurg, 1.09 for TMD,
1.11 for ﬁbromyalgia, 1.51 for migraine and 1.04 for DN4-determined
neuropathic pain.
The threshold for genome-wide signiﬁcance was corrected for multiple testing
with a weighted Bonferroni adjustment using as weights the enrichment of variant
classes with predicted functional impact among association signals21. With
21,568,490 sequence variants being tested, the weights given in the study by
Sveinbjornsson et al.21 were rescaled to control the family-wise error rate. This
yielded signiﬁcance thresholds of 3.7 10 7 for high-impact variants (N¼ 6,308),
7.4 10 8 for moderate-impact variants (N¼ 121,793), 5.3 10 9 for
low-impact variants (N¼ 1,329,163), 3.4 10 9 for other DNase I hypersensitivity
sites (DHS) variants (N¼ 3,262,787) and 1.1 10 9 for other non-DHS variants
(N¼ 16,848,439).
In our data, 37 variants, all located at chr8:129,705,470–129,726,726 (hg38),
associated signiﬁcantly with LDHsurg. We performed conditional analysis
for all variants with info40.9 that are positioned within ±2Mb of these
37 variants, with rs6651255[C] the variant with the most signiﬁcant association,
as a covariate. No variants in the area had a signiﬁcant adjusted P value
(all adjusted P42.3 10 4).
Logistic regression was performed for LDHsurg case–control status, adjusting
for gender and county of origin, with height in terms of SD in cm as explanatory
variable (Ncase¼ 1,929; Ncontrol¼ 79,883).
To generate height polygenic risk scores, GWAS results for 2,550,858 variants
were computed based on GIANT37 data after having removed Icelandic samples.
Imputed genetic variants were available for 3,085 adult LDHsurg cases and
132,822 controls. Of the GWAS variants which were also available in the
imputation set, 1,746,527 were biallelic SNPs and met quality control standards.
LDpred63 was used to adjust for the correlation among the effects of these variants
due to linkage disequilibrium and these adjusted effects were used to produce the
adult height polygenic score. Logistic regression was performed for LDHsurg
case–control status, adjusting for gender and county of origin, with the polygenic
score as explanatory variable. To put the odds ratios for one unit increase in
polygenic score in terms of increase in ten cm, we ran a linear regression for adult
height in terms of SD in cm with the polygenic score as explanatory variable
(N¼ 80,546). The regression slope for the polygenic score (b¼ 5.5,
Po1 10 300) was then used to estimate how many units of the polygenic score
would increase height by 10 cm (1.8¼ 10/5.5 units).
Data availability. Data supporting the ﬁndings of this study are available
within the article and its Supplementary Information ﬁles. Summary level
data of markers tested for association is described in Scientiﬁc data as of 2015 with
the identiﬁer http://dx.doi.org/10.1038/sdata.2015.11 (ref. 64). Whole-genome
sequencing summary data are available at the European Variant Archive
(EVA, https://www.ebi.ac.uk/eva/) under the accession code PRJEB8636.
GTEx data (http://www.gtexportal.org) accessed 8 August 2016;
LD Score Database (ftp://atguftp.mgh.harvard.edu/brendan/
1k_eur_r2_hm3snps_se_weights.RDS) accessed 23 June 2015; GWAS catalogue
(https://www.ebi.ac.u/gwas/home) accessed 8 September 2016.
References
1. Ropper, A. H. & Zafonte, R. D. Sciatica. N. Engl. J. Med. 372, 1240–1248
ð2015Þ:
2. Valat, J. P., Genevay, S., Marty, M., Rozenberg, S. & Koes, B. Sciatica. Best Pract.
Res. Clin. Rheumatol. 24, 241–252 (2010).
3. Mixter, W. J. & Barr, J. S. Rupture of the intervertebral disc with involvement of
the spinal canal. N. Engl. J. Med. 211, 210–215 (1934).
4. Winkelstein, B. A., Allen, K. D. & Setton, L. A. in The Intervertebral Disc
(eds Shapiro, L. M. & Risbud, M. V.) 305–326 (Springer-Verlag, Wien,
2014).
5. Kjaer, P., Leboeuf-Yde, C., Korsholm, L., Sorensen, J. S. & Bendix, T. Magnetic
resonance imaging and low back pain in adults: a diagnostic imaging study
of 40-year-old men and women. Spine (Phila Pa 1976) 30, 1173–1180
ð2005Þ:
6. Kjaer, P., Leboeuf-Yde, C., Sorensen, J. S. & Bendix, T. An epidemiologic study
of MRI and low back pain in 13-year-old children. Spine (Phila Pa 1976) 30,
798–806 (2005).
7. Cheung, K. M. et al. Prevalence and pattern of lumbar magnetic resonance
imaging changes in a population study of one thousand forty-three individuals.
Spine (Phila Pa 1976) 34, 934–940 (2009).
8. Sambrook, P. N., MacGregor, A. J. & Spector, T. D. Genetic inﬂuences on
cervical and lumbar disc degeneration: a magnetic resonance imaging study in
twins. Arthritis Rheum. 42, 366–372 (1999).
9. Battie, M. C. et al. Similarities in degenerative ﬁndings on magnetic resonance
images of the lumbar spines of identical twins. J. Bone Joint Surg. Am. 77,
1662–1670 (1995).
10. Battie, M. C. & Videman, T. Lumbar disc degeneration: epidemiology and
genetics. J. Bone Joint Surg. Am. 88(Suppl 2): 3–9 (2006).
11. Eskola, P. J. et al. Genetic association studies in lumbar disc degeneration: a
systematic review. PLoS ONE 7, e49995 (2012).
12. Williams, F. M. et al. Novel genetic variants associated with lumbar disc
degeneration in northern Europeans: a meta-analysis of 4600 subjects. Ann.
Rheum. Dis. 72, 1141–1148 (2013).
13. Kreiner, D. S. et al. An evidence-based clinical guideline for the diagnosis and
treatment of lumbar disc herniation with radiculopathy. Spine J. 14, 180–191
(2014).
14. Brinjikji, W. et al. Systematic literature review of imaging features of spinal
degeneration in asymptomatic populations. Am. J. Neuroradiol. 36, 811–816
(2015).
15. Haldeman, S. North American Spine Society: failure of the pathology model to
predict back pain. Spine (Phila Pa 1976) 15, 718–724 (1990).
16. Atlas, S. J., Keller, R. B., Wu, Y. A., Deyo, R. A. & Singer, D. E. Long-term
outcomes of surgical and nonsurgical management of sciatica secondary to
a lumbar disc herniation: 10 year results from the maine lumbar spine study.
Spine (Phila Pa 1976) 30, 927–935 (2005).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14265
6 NATURE COMMUNICATIONS | 8:14265 | DOI: 10.1038/ncomms14265 | www.nature.com/naturecommunications
17. Soliman, J. et al. Limited microdiscectomy for lumbar disk herniation: a
retrospective long-term outcome analysis. J. Spinal Disord. Tech. 27, E8–E13
(2014).
18. Artus, M., van der Windt, D., Jordan, K. P. & Croft, P. R. The clinical course of
low back pain: a meta-analysis comparing outcomes in randomised clinical
trials (RCTs) and observational studies. BMC Musculoskelet. Disord. 15, 68
(2014).
19. Konstantinou, K. & Dunn, K. M. Sciatica: review of epidemiological
studies and prevalence estimates. Spine (Phila Pa 1976) 33, 2464–2472
ð2008Þ:
20. Jensdottir, M., Gudmundsson, K., Hannesson, B. & Gudmundsson, G. 20 years
follow-up after the ﬁrst microsurgical lumbar discectomies in Iceland. Acta
Neurochir. (Wien) 149, 51–58 (2007).
21. Sveinbjornsson, G. et al.Weighting sequence variants based on their annotation
increases power of whole-genome association studies. Nat. Genet. 48, 314–317
(2016).
22. Tseng, Y. Y. et al. PVT1 dependence in cancer with MYC copy-number
increase. Nature 512, 82–86 (2014).
23. Ghoussaini, M. et al. Multiple loci with different cancer speciﬁcities within the
8q24 gene desert. J. Natl Cancer. Inst. 100, 962–966 (2008).
24. Amundadottir, L. T. et al. A common variant associated with prostate
cancer in European and African populations. Nat. Genet. 38, 652–658
ð2006Þ:
25. Gudmundsson, J. et al. A common variant at 8q24.21 is associated with renal
cell cancer. Nat. Commun. 4, 2776 (2013).
26. Stacey, S. N. et al. A germline variant in the TP53 polyadenylation signal
confers cancer susceptibility. Nat. Genet. 43, 1098–1103 (2011).
27. Watabe, K. et al. Structure, expression and chromosome mapping of MLZE,
a novel gene which is preferentially expressed in metastatic melanoma cells. Jpn
J. Cancer Res. 92, 140–151 (2001).
28. Tamura, M. & Shiroishi, T. GSDM family genes meet autophagy. Biochem.
J. 469, e5–e7 (2015).
29. Shi, J. et al. Cleavage of GSDMD by inﬂammatory caspases determines
pyroptotic cell death. Nature 526, 660–665 (2015).
30. Shi, P. et al. Loss of conserved Gsdma3 self-regulation causes autophagy and
cell death. Biochem. J. 468, 325–336 (2015).
31. Saeki, N. & Sasaki, H. in Endothelium and Epithelium (eds Carrasco, J. & Mota,
M.) 193-211 (Nova Science Publishers, Inc., 2012).
32. Yin, W., Rossin, A., Clifford, J. L. & Gronemeyer, H. Co-resistance to retinoic
acid and TRAIL by insertion mutagenesis into RAM. Oncogene 25, 3735–3744
(2006).
33. Hirano, T. et al. Genes encoded within 8q24 on the amplicon of a large
extrachromosomal element are selectively repressed during the terminal
differentiation of HL-60 cells. Mutat. Res. 640, 97–106 (2008).
34. Williams, J. A. et al. Retinoic acid receptors are required for skeletal growth,
matrix homeostasis and growth plate function in postnatal mouse. Dev. Biol.
328, 315–327 (2009).
35. Birnbaum, S. et al. Key susceptibility locus for nonsyndromic cleft lip
with or without cleft palate on chromosome 8q24. Nat. Genet. 41, 473–477
(2009).
36. Lango Allen, H. et al. Hundreds of variants clustered in genomic loci
and biological pathways affect human height. Nature 467, 832–838
ð2010Þ:
37. Wood, A. R. et al. Deﬁning the role of common variation in the genomic and
biological architecture of adult human height. Nat. Genet. 46, 1173–1186
(2014).
38. He, M. et al. Meta-analysis of genome-wide association studies of adult
height in East Asians identiﬁes 17 novel loci. Hum. Mol. Genet. 24, 1791–1800
(2015).
39. Locke, A. E. et al. Genetic studies of body mass index yield new insights for
obesity biology. Nature 518, 197–206 (2015).
40. Wahlstrom, J., Burstrom, L., Nilsson, T. & Jarvholm, B. Risk factors for
hospitalization due to lumbar disc disease. Spine (Phila Pa 1976) 37, 1334–1339
(2012).
41. Styrkarsdottir, U. et al. Sequence variants in the PTCH1 gene associate with
spine bone mineral density and osteoporotic fractures. Nat. Commun. 7, 10129
(2016).
42. Campbell, Jr. W. W., Ward, L. C. & Swift, T. R. Nerve conduction velocity
varies inversely with height. Muscle Nerve 4, 520–523 (1981).
43. Adler, A. I. et al. Risk factors for diabetic peripheral sensory neuropathy.
Results of the Seattle Prospective Diabetic Foot Study. Diabetes Care 20,
1162–1167 (1997).
44. Cheng, Y. J. et al. Peripheral insensate neuropathy--a tall problem for US
adults? Am. J. Epidemiol. 164, 873–880 (2006).
45. Evans, S. R. et al. Peripheral neuropathy in HIV: prevalence and risk factors.
AIDS 25, 919–928 (2011).
46. Smith, W. C., Bourne, D., Squair, J., Phillips, D. O. & Chambers, W. A. A
retrospective cohort study of post mastectomy pain syndrome. Pain 83, 91–95
(1999).
47. Ho, K. C., Gwozdz, J. T., Hause, L. L. & Antuono, P. G. Correlation of neuronal
cell body size in motor cortex and hippocampus with body height, body weight,
and axonal length. Int. J. Neurosci. 65, 147–153 (1992).
48. Weinstein, J. N. et al. Surgical vs nonoperative treatment for lumbar disk
herniation: the Spine Patient Outcomes Research Trial (SPORT): a randomized
trial. JAMA 296, 2441–2450 (2006).
49. Parker, S. L. et al. Incidence of low back pain after lumbar discectomy for
herniated disc and its effect on patient-reported outcomes. Clin. Orthop. Relat.
Res. 473, 1988–1999 (2015).
50. Olmarker, K. et al. Inﬂammatogenic properties of nucleus pulposus. Spine
(Phila Pa 1976) 20, 665–669 (1995).
51. Mulleman, D., Mammou, S., Griffoul, I., Watier, H. & Goupille, P.
Pathophysiology of disk-related sciatica. I.--evidence supporting a chemical
component. Joint Bone Spine 73, 151–158 (2006).
52. Mebius, R. E. & Kraal, G. Structure and function of the spleen. Nat. Rev.
Immunol. 5, 606–616 (2005).
53. Risbud, M. V. & Shapiro, I. M. Role of cytokines in intervertebral disc
degeneration: pain and disc content. Nat. Rev. Rheumatol. 10, 44–56 (2014).
54. Nordic Medico-Statistical Committee. NOMESCO Classiﬁcation of Surgical
Procedures (NCSP) (Nordic Medico-Statistical Committee, 2011).
55. Gormley, P. et al. Meta-analysis of 375,000 individuals identiﬁes 38
susceptibility loci for migraine. Nat. Genet. 48, 856–866 (2016).
56. Wolfe, F. et al. The American College of Rheumatology preliminary diagnostic
criteria for ﬁbromyalgia and measurement of symptom severity. Arthritis Care
Res. (Hoboken) 62, 600–610 (2010).
57. Schiffman, E. et al. Diagnostic criteria for temporomandibular disorders
(DC/TMD) for clinical and research applications: recommendations of the
International RDC/TMD Consortium Network* and Orofacial Pain Special
Interest Groupdagger. J. Oral Facial Pain Headache 28, 6–27 (2014).
58. Bouhassira, D. et al. Comparison of pain syndromes associated with nervous or
somatic lesions and development of a new neuropathic pain diagnostic
questionnaire (DN4). Pain 114, 29–36 (2005).
59. Gulcher, J. R., Kristjansson, K., Gudbjartsson, H. & Stefansson, K. Protection of
privacy by third-party encryption in genetic research in Iceland. Eur. J. Hum.
Genet. 8, 739–742 (2000).
60. Gudbjartsson, D. F. et al. Large-scale whole-genome sequencing of the Icelandic
population. Nat. Genet. 47, 435–444 (2015).
61. McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for
analyzing next-generation DNA sequencing data. Genome Res. 20, 1297–1303
(2010).
62. Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from
polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295
(2015).
63. Vilhjalmsson, B. J. et al. Modeling linkage disequilibrium increases accuracy of
polygenic risk scores. Am. J. Hum. Genet. 97, 576–592 (2015).
64. Gudbjartsson, D. F. et al. Sequence variants from whole genome sequencing a
large group of Icelanders. Sci. Data 2, 150011 (2015).
Acknowledgements
We thank the participants, research nurses and staff at the Patient Recruitment Center,
clinical data management specialists at the Landspitali University Hospital, and all clinical
collaborators and colleagues who contributed to phenotype ascertainment, recruitment,
collection of data, sample handling and genotyping. The ﬁnancial support from the Eur-
opean Commission to the NeuroPain project (FP7#HEALTH-2013-602891-2) and the
National Institutes of Health (R01DE022905) is acknowledged.
Author contributions
G.B., S.B., P.S., D.G., U.T., H.S., T.E.T. and K.S. designed the study and interpreted
results. G.B., U.S., T.G., A.B., I.H.O., E.U., A.V., R.H., K.O.K., T.R., I.J. and T.E.T. carried
out case ascertainment. G.B., S.B., A.O., M.L.F., A.K., G.M., G.S., U.S., G.T., G.B.W.,
O.T.M., P.S. and D.G. performed statistical and bioinformatics analyses. G.B., S.B., T.G.,
A.B., I.H.O., E.U., P.S., D.G., U.T., H.S., T.E.T and K.S. drafted the manuscript. All
authors contributed to the ﬁnal version of the paper.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing ﬁnancial interests: The authors declare competing ﬁnancial interest. G.B.,
S.B., A.O., M.L.F., A.K., G.M., U.S., G.S., G.T., G.B.W., O.T.M., U.T., P.S., D.G., H.S.,
T.R., I.J., T.E.T. & K.S. are employees of deCODE Genetics/Amgen, Inc.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14265 ARTICLE
NATURE COMMUNICATIONS | 8:14265 | DOI: 10.1038/ncomms14265 |www.nature.com/naturecommunications 7
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Bjornsdottir, G. et al. Sequence variant at 8q24.21
associates with sciatica caused by lumbar disc herniation. Nat. Commun. 8, 14265
doi: 10.1038/ncomms14265 (2017).
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional afﬁliations.
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
r The Author(s) 2017
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms14265
8 NATURE COMMUNICATIONS | 8:14265 | DOI: 10.1038/ncomms14265 | www.nature.com/naturecommunications
